Literature DB >> 19794441

Dronedarone.

Richard L Page, Bashar Hamad, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19794441     DOI： 10.1038/nrd2998

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  14 in total

1.  Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone.

Authors:  W Sun; J S Sarma; B N Singh
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

2.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

Authors:  Karin S Coyne; Clark Paramore; Susan Grandy; Marco Mercader; Matthew Reynolds; Peter Zimetbaum
Journal:  Value Health       Date:  2006 Sep-Oct       Impact factor: 5.725

Review 3.  Drug therapy for atrial fibrillation: where do we go from here?

Authors:  Richard L Page; Dan M Roden
Journal:  Nat Rev Drug Discov       Date:  2005-11       Impact factor: 84.694

4.  Increased mortality after dronedarone therapy for severe heart failure.

Authors:  Lars Køber; Christian Torp-Pedersen; John J V McMurray; Ole Gøtzsche; Samuel Lévy; Harry Crijns; Jan Amlie; Jan Carlsen
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

5.  Effect of dronedarone on cardiovascular events in atrial fibrillation.

Authors:  Stefan H Hohnloser; Harry J G M Crijns; Martin van Eickels; Christophe Gaudin; Richard L Page; Christian Torp-Pedersen; Stuart J Connolly
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

6.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

7.  Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

Authors:  Bramah N Singh; Stuart J Connolly; Harry J G M Crijns; Denis Roy; Peter R Kowey; Alessandro Capucci; David Radzik; Etienne M Aliot; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2007-09-06       Impact factor: 91.245

8.  Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.

Authors:  Stuart J Connolly; Harry J G M Crijns; Christian Torp-Pedersen; Martin van Eickels; Christophe Gaudin; Richard L Page; Stefan H Hohnloser
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

9.  Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.

Authors:  Denis Roy; Craig M Pratt; Christian Torp-Pedersen; D George Wyse; Egon Toft; Steen Juul-Moller; Tonny Nielsen; S Lind Rasmussen; Ian G Stiell; Benoit Coutu; John H Ip; Edward L C Pritchett; A John Camm
Journal:  Circulation       Date:  2008-03-10       Impact factor: 29.690

10.  Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.

Authors:  O Finance; A Manning; P Chatelain
Journal:  J Cardiovasc Pharmacol       Date:  1995-10       Impact factor: 3.105
View more
  3 in total

1.  Vernakalant.

Authors:  Dobromir Dobrev; Bashar Hamad; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

2.  Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.

Authors:  David P Kao; William R Hiatt; Mori J Krantz
Journal:  Pharmacotherapy       Date:  2012-06-28       Impact factor: 4.705

3.  Dronedarone in patients with atrial fibrillation.

Authors:  N M S de Groot; C J Kirchhof; I C van Gelder; J G Meeder; A H M M Balk; A A Wilde; M L Simoons
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.